Please use this identifier to cite or link to this item:
http://111.93.178.142:25000/jspui/handle/123456789/5197Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Suresh Bairi | - |
| dc.date.accessioned | 2026-06-08T06:09:37Z | - |
| dc.date.available | 2026-06-08T06:09:37Z | - |
| dc.date.issued | 2026-06-08 | - |
| dc.identifier.uri | http://111.93.178.142:25000/jspui/handle/123456789/5197 | - |
| dc.description | Vol. 36, No. 1, p 23 | en_US |
| dc.language.iso | en | en_US |
| dc.subject | Oxadiazole-imidazole hybrids | en_US |
| dc.subject | Molecular docking | en_US |
| dc.subject | Epidermal growth factor receptor/human epidermal growth factor recrptor 2 inhibitors | en_US |
| dc.subject | In silico absrption | en_US |
| dc.subject | distribution | en_US |
| dc.subject | metabolism | en_US |
| dc.subject | excreation profling | en_US |
| dc.subject | Anticancer drug design | en_US |
| dc.title | Docking studies of 1,2,4- oxadiazole incorporated (2-(oxazol)-1H-imidazole) derivatives a anticancer agents | en_US |
| dc.type | Other | en_US |
| Appears in Collections: | Vol. 36, No. 1, 2026 | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| 1.pdf | Vol. 36, No. 1, p 23 | 139.55 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.